Why the study?
Does the determination of the upper limit of vulnerability (ULV) provide better reproducibility than the defibrillation threshold (DFT) in patients with a transvenous implantable cardioverter defibrillator?
Does the determination of the upper limit of vulnerability (ULV) provide better reproducibility than the defibrillation threshold (DFT) in patients with a transvenous implantable cardioverter defibrillator?
The upper limit of vulnerability is a more reproducible measure than the single point defibrillation threshold for evaluating defibrillation efficacy.
No takes yet. Share an insight, caveat, or question.
ULV may offer more reproducible defibrillation assessment than DFT in transvenous ICD patients; leaves open whether adoption improves outcomes and requires prospective validation.
Swerdlow et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: